John M Byers, MD | |
1132 N Church St, Suite 200, Greensboro, NC 27401-1039 | |
(336) 379-9445 | |
(336) 691-1704 |
Full Name | John M Byers |
---|---|
Gender | Male |
Speciality | Otolaryngology |
Experience | 35 Years |
Location | 1132 N Church St, Greensboro, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194779140 | NPI | - | NPPES |
8920573 | Medicaid | NC | |
20573 | Other | NC | BCBS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 9400430 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Moses Cone Physician Services, Inc | 4284782210 | 306 |
News Archive
"My results show that people's individual Christian faith becomes present during times of personal crisis. Faith and hope manifest themselves very intensely, but it is rare that they show in the classical forms we normally associate with Christianity.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
The dramatic shift in how nasal tip surgery is being performed given changes in the intended goals and evolving techniques is highlighted in a Special Communication by and interview with Dean Toriumi, MD, published in the Official Journal of the American Academy of Facial Plastic and Reconstructive Surgery, Facial Plastic Surgery & Aesthetic Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.
› Verified 6 days ago
Entity Name | Wake Forest Health Network Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477785756 PECOS PAC ID: 4183538895 Enrollment ID: O20031117000868 |
News Archive
"My results show that people's individual Christian faith becomes present during times of personal crisis. Faith and hope manifest themselves very intensely, but it is rare that they show in the classical forms we normally associate with Christianity.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
The dramatic shift in how nasal tip surgery is being performed given changes in the intended goals and evolving techniques is highlighted in a Special Communication by and interview with Dean Toriumi, MD, published in the Official Journal of the American Academy of Facial Plastic and Reconstructive Surgery, Facial Plastic Surgery & Aesthetic Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.
› Verified 6 days ago
Entity Name | Moses Cone Physician Services, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093953127 PECOS PAC ID: 4284782210 Enrollment ID: O20090501000202 |
News Archive
"My results show that people's individual Christian faith becomes present during times of personal crisis. Faith and hope manifest themselves very intensely, but it is rare that they show in the classical forms we normally associate with Christianity.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
The dramatic shift in how nasal tip surgery is being performed given changes in the intended goals and evolving techniques is highlighted in a Special Communication by and interview with Dean Toriumi, MD, published in the Official Journal of the American Academy of Facial Plastic and Reconstructive Surgery, Facial Plastic Surgery & Aesthetic Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
John M Byers, MD 1701 Westchester Dr, Suite 850, High Point, NC 27262-7008 Ph: (336) 802-2536 | John M Byers, MD 1132 N Church St, Suite 200, Greensboro, NC 27401-1039 Ph: (336) 379-9445 |
News Archive
"My results show that people's individual Christian faith becomes present during times of personal crisis. Faith and hope manifest themselves very intensely, but it is rare that they show in the classical forms we normally associate with Christianity.
Vertex Pharmaceuticals Incorporated today announced the initiation of a Phase 2a clinical trial that will evaluate multiple combinations of VX-770 and VX-809, investigational oral cystic fibrosis transmembrane conductance regulator (CFTR) modulators for the treatment of cystic fibrosis (CF). The trial is designed to evaluate the safety and tolerability of VX-809 dosed alone for 14 days followed by dosing of VX-809 in combination with VX-770 for 7 days.
The dramatic shift in how nasal tip surgery is being performed given changes in the intended goals and evolving techniques is highlighted in a Special Communication by and interview with Dean Toriumi, MD, published in the Official Journal of the American Academy of Facial Plastic and Reconstructive Surgery, Facial Plastic Surgery & Aesthetic Medicine, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.
› Verified 6 days ago
Dwight D Bates, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1132 N Church St, Suite 200, Greensboro, NC 27401 Phone: 336-379-9445 Fax: 336-691-1704 | |
James J Lee, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 321 W Wendover Ave, Greensboro, NC 27408 Phone: 336-379-9445 Fax: 336-691-1704 | |
Mitchell Ray Gore, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1132 N Church St, Suite 200, Greensboro, NC 27401 Phone: 336-802-2536 Fax: 336-802-2534 | |
David L Shoemaker, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1132 N Church St, Suite 200, Greensboro, NC 27401 Phone: 336-379-9445 Fax: 336-691-1704 | |
Karol T Wolicki, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1132 N Church St, Suite 200, Greensboro, NC 27401 Phone: 336-379-9445 Fax: 336-691-1704 | |
Dr. Christopher Ernest Newman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 100 E Northwood St, Greensboro, NC 27401 Phone: 336-230-2434 Fax: 336-230-1540 |